Short stature and failure of pubertal development in thalassaemia major: Evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion

European Journal of Pediatrics

Volumn 156, Issue 10, 1997, Pages 777-783

  Roth, C ^a   Pekrun, A ^a   Bartz, M ^a   Jarry, H ^b   Eber, S ^a   Lakomek, M ^a   Schroten W ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Androgen priming; Gonadotropins; Growth hormone; Neurosecretory dysfunction; Thalassaemia major

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; DELAYED PUBERTY; ESTRADIOL BLOOD LEVEL; FEMALE; GROWTH HORMONE RELEASE; HEMOCHROMATOSIS; HUMAN; HYPOPHYSIS FUNCTION; MALE; PRIORITY JOURNAL; PUBERTY; SHORT STATURE; TESTOSTERONE BLOOD LEVEL;

EID: 0030867354     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050711     Document Type: Article

References (39)

1. Albertsson-Wikland K, Rosberg S (1988) Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 67:493-500
2. Bierich JR, Brügmann G, Kiessling E (1989) Spontansekretion des Wachstumshormons im nächtlichen Tiefschlaf. Monatsschr Kinderheilkd 137:80-85
3. Bozzola M, Argente J, Cisternino M, Moretta A, Valtorta A, Biscaldi I, Donnadieu M, Evain-Brion D, Severi F (1989) Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassaemia major. Eur J Pediatr 148:300-303
4. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ (1990) Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. N Engl J Med 323:713-719
5. Butenandt O (1994) In: Ranke MB, Stolecke H (eds) Diagnostik des Wachstumshormonmangels. Aktuelle methodische und klinische Aspekte. Dokument + Bild. Ankum-Kettenkamp, Germany, pp 107-120
6. Caruso-Nicoletti M, Mancuse M, Spadaro G, Presti DL, Conversano M (1996) Response to growth hormone treatment in thalassemic patients. (abstract) International Congress of Endocrinology, San Francisco. The Endocrine Society, Bethesda, USA, P3-43
7. Chalew SA, Udoff LC, Hanukoglu A, Bistritzer T, Armour KM, Kowarski AA (1988) The effect of testosterone therapy on spontaneous growth hormone secretion in boys with constitutional delay. Am J Dis Child 142:1345-1348
8. Chatterjee R, Katz M, Cox T, Bantock H (1943) Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test. Eur J Pediatr 152:721-726
9. Delemarre-van de Waul, HA, Brande JL van den, Schoemaker J (1985) Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects. J Clin Endocrinol Metab 61:859-867
10. De Sanetis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B (1994) Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. Clin Endocrinol Oxf 40:791-798
11. Dickerman Z, Prager-Lewin R, Laron Z (1976) The effect of repeated injections of synthetic luteinizing hormone-releasing hormone on the response of plasma luteinizing hormone and follicle-stimulating hormone in young hypogonadotropic-hypogonadal patients. Fertil Steril 27:162-166
12. Gabutti V, Piga A (1996) Results of long-term iron-chelating therapy. Acta Haematol 95:26-36
13. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press. Stanford. California
14. Hatori M, Sparkman J, Teixeira CC, Grynpas M, Nervina J, Olivieri N, Shapiro IM (1995) Effects of deferoximine on chondrocyte alkaline phosphatase activity: peroxidant role of deferoximine in thalassemia. Calcif Tissue Int 57:229-236
15. Hochberg Z, Shehadeh N, Rudolf MCJ, Peleg I, Hazani A (1990) Neurosecretory dysfunction of growth hormone secretion in thalassaemia major. Acta Paediatr Scand [Suppl] 370:198
16. Illig R, Bucher H (1983) Testosterone priming of growth hormone release. Pediatr Adolesc Endocr 12:75-85
17. Kattamis C, Liakopoulou T, Kattamis A (1990) Growth and development in children with thalassaemia major. Acta Paediatr Scand 366:111-117
18. Katz M, DeSanctis V, Vullo C, Wonke B, Mc Garrigle HH, Bagni B (1993) Pharmacokinetics of sex steroids in patients with beta thalassemia major. J Clin Pathol 46: 660-664
19. Katz M, DeSanctis V, Vullo C, Wonke B, Ughi M, Pinamonti A, Sprocatti M, Gamberini MR, Bagni B (1995) Spermatogenesis in patients with β-thalassemia major and intermedia. In Ando S, Brancadi C (eds) Endocrine disorders in thalassemia. Springer, Berlin Heiderberg New York, pp 19-24
20. Katzos G, Harsoulis F, Papadopoulou M, Athanasiou M, Sava K (1995) Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major, Eur J Pediatr 154:445-449
21. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER (1993) Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 76:996-1001
22. Kwan EY, Lee AC, Li AM, Tam SC, Chan CE, Lau YL, Low LC (1995) A cross-sectional study of growth, puberty and endocrine function in patients with thalassemia major in Hong Kong. J Pediatr Child Health 31:83-87
23. Largo RH, Prader A (1983) Pubertal development in Swiss boys. Helv Paediatr Acta 38:211-228
24. Leger J, Girot R, Crosnier H, Postel-Vinay MC, Rappaport R (1989) Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J Clin Endocrinol Metab 69:453-456
25. Levin TL, Sheth S, Berdon WE, Ruzal-Shapiro C, Piomelli S (1995) Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients. Pediatr Radiol 25:122-124
26. Low LCK, Kwan EYW, Lim YJ, Lee ACW, Tam CF, Lam KSL (1995) Growth hormone treatment of short Chinese children with β-thalassaemia major without GH deficiency. Clin Endocrinol 42:359-363
27. Martin LG, Grossman MS, Connor TB, Levitsky LL, Clark JW, Camitta FD (1979) Effect of androgen on growth hormone secretion and growth in boys with short stature. Acta Endocrinol 91:201-212
28. Merriam GR, Wachter KW (1982) Algorithms for the study of episodic hormone secretion. Am J Physiol 243: E310-E318
29. Oerter KE, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK (1993) Multiple hormone deficiencies in patients with hemochromatosis. J Clin Endocrinol Metab 76: 357-361
30. Piperno A, Rivolta MR, D'Alba R, Fargion S, Rovelli F, Ghezzi A, Micheli M, Fiorelli G (1992) Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction. J Endocrinol Invest 15:423-428
31. Postel-Vinay MC, Girot R, Leger J, Hocquette JF, McKelvie P, Amar-Costesec A, Rappaport R (1989) No evidence for a defect in growth hormone binding to liver membranes in thalassemia major. J Clin Endocrinol Metab 68:94-98
32. Prader A, Largo RH, Wälli R, Fanconi A (1980) Schweizerische Wachstumskurven von der 28. Schwangerschaftswoche bis zum 18. Lebensjahr. Helv Paediatr Acta [Suppl] 45:32
33. Prader A, Largo RH, Molinari, Issler C (1988) Physical growth of Swiss children from birth to 20 years of age: first Zürich longitudinal study of growth and development. Helv Paediatr Acta [Suppl 52]:1-125
34. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK (1995) Short stature in homozygous β-thalassaemia is due to disproportionate truncal shortening. Clin Endocrinol 42:587-592
35. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgartner MW (1980) Depressed serum somatomedin activity in β-thalassemia. J Pediatr 96:214-218
36. Shehadeh N, Hazani A, Rudolf MCJ, Peleg I, Benderly A, Hochberg Z (1990) Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand 79:790-795
37. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB (1984) Growth hormone neurosecretory dysfunction. JAMA 251:2223-2230
38. Wang C, Tso SC, Todd D (1989) Hypogonadotropic hypogonadism in severe β-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab 68:511-516
39. Werther GA, Matthews RN, Burger HG, Herington AC (1981) Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. J Clin Endocrinol Metab 53:806-809